In this study, we intended to evaluate the carcinogenic effect of AB1 on tumor-suppressing genes (BRCA1, BRCA2, and p53), oncogenes (HER1, HER2, and cMyc), cell cycle genes (CCND1, WNT3A MAPK1, and MAPK3), and apoptosis genes (BCL2, MCL1, DAPK1, Casp8, and Casp9). The gene discussed is ERBB2; the disease is neoplasm.